- Opinion
- [Reporter’s View] Interest in the role and vision of GAs
- by Eo, Yun-Ho Apr 26, 2021 05:51am
- Multinational pharmaceutical companies have been eagerly hiring employees for Government Affairs (GA). Even companies that originally had no such position have newly created the position. Until now, the distinction between areas covered by Market Access (MA) and GA was unclear, and GA's target 'government institutions’ were limited to
- Company
- Ninlaro can be prescribed at general hospitals
- by Eo, Yun-Ho Apr 26, 2021 01:34am
- Ninlaro, an oral multiple myeloma treatment that solves the problem of insurance benefits, is prescribed at general hospitals. According to related industries, Ninlaro (Ixazomib), an oral medication option in the field of multiple myeloma (MM), is used in Korea, including Samsung Medical Center, Seoul National University Hospital, the Cath
- Policy
- Rucalo & Xeljanz are subject to usage monitoring in 2Q
- by Lee, Hye-Kyung Apr 26, 2021 01:32am
- Yooyoung Pharmaceutical's chronic constipation treatment Rucalo(Prucalopride Succinate) 1mg and 2mg were included in the price volume agreement monitoring. Pfizer Korea's Xeljanz (Tofacitinib Citrate) 5-10mg, Novartis Korea's Revolade (Eltrombopag) 25-50mg also decreases in price due to drug price negotiations as the usage increases. The N
- Company
- The market share of Hanmi & Chong Kun Dang's is 16%
- by Kim, Jin-Gu Apr 26, 2021 01:29am
- Competition for the generic drug Betmiga (Mirabegron), an overactive bladder treatment, is intensifying in the outpatient prescription market. According to the drug market research agency UBIST on the 20th, the Mirabegron market scale in the first quarter reached &8361;18.3 billion. It increased by 9% compared to &8361;16.7 billion in th
- Company
- Domestic drug Rosuzet/K-CAB sales performance is very good
- by An, Kyung-Jin Apr 26, 2021 01:28am
- Lipitor, a treatment for hyperlipidemia, kept the lead in outpatient prescription sales. Drugs developed with domestic technology such as Rosuzet and Zemiglo, led by HK inno.N's K-CAB, increased sales despite prolonged COVID-19. Original drugs are on a decreasing trend after patent expiration. According to UBIST, a drug research institute on
- Tamiflu hit hard by COVID-19, prescription drops 99.9%
- by Chon, Seung-Hyun Apr 23, 2021 05:53am
- The market for the influenza (flu) treatment ‘Tamiflu’ has virtually become moribund this year. Its market size fell 99.9% due to the rapid drop of flu cases in the prolonged coronavirus disease-2019 (COVID-19) pandemic. According to the pharmaceutical market data research firm UBIST on the 22nd, outpatient prescription of ‘oseltamivir’ r
- Company
- Big 5 Hospitals actively prepare CAR-T ‘Kymria' centers
- by Eo, Yun-Ho Apr 22, 2021 05:53am
- The ‘Big-5’ tertiary hospitals in Korea are working fast to introduce the first CAR-T therapy ‘Kymriah’ to their institutions. According to industry officials, among the Big-5s, Seoul National University Hospital (SNUH), Asan Medical Center (AMC), Seoul St. Mary’s Hospital, and Severance Hospital are in the process of acquiring the
- Company
- Tremfya reimbursement approved for palmoplantar pustulosis
- by Apr 22, 2021 05:53am
- Janssen’s interlukin-23 (IL-23) inhibitor ‘Tremfya (guselkumab)’ will be reimbursed from May 1st for the treatment of palmoplantar pustulosis. The reimbursement will apply to patients over the age of 18 years who were diagnosed with moderate to severe palmoplantar pustulosis that has lasted for more than 6 months that ▲ have a Palmo
- Company
- Sanofi to sell Hanmi's AmosartanQ' in Russia
- by An, Kyung-Jin Apr 22, 2021 05:53am
- Hanmi's IMD AmosartanQ will be launched in the Russian market through Sanofi. Hanmi announced on the 20th that Sanofi has obtained marketing approval from the MOH for AmosartanQ under the product name Tristanium. AmosartanQ is a combination drug that combines Amlodipine Camsylate, a component for treating hypertension of CCB, and Losart
- Product
- Why are pharmacists in the AZ vaccination relay?
- by Apr 22, 2021 05:53am
- On social media, pharmacists' vaccination application reservation verification shots appeared in a row. "I made an appointment for vaccination", "I applied for it too" Since yesterday (19th), a vaccine application for pharmacies through the KCDA website has been in progress, and pharmacists who have completed reservations are sharing informa
